March 3, 2025

Ron Finklestien

Stock Under Pressure: Arcosa (ACA)

Arcosa’s Strong Sell Rating Reflects Ongoing Challenges

https://www.youtube.com/watch?v=9SYyZTRY_9U[/embed>

Currently, the Zacks Building Products-Miscellaneous Industry ranks in the bottom 19% of 246 Zacks industries, indicating significant concerns. Arcosa ACA has earned a Zacks Rank #5 (Strong Sell) and is identified as the “Bear of the Day.”

The infrastructure product manufacturer is grappling with several operational issues amid daunting market conditions. Recently, the Indiana Department of Environmental Management (IDEM) issued a notice to Arcosa’s aggregates division (Arcosa Lightweight) regarding possible emissions violations.

Disappointing Q4 Performance

In early February, Arcosa reported its Q4 results, with sales increasing by 14% year-over-year to $666.2 million. However, this figure fell short of estimates of $694.2 million by 4%.

More troubling, Arcosa noted a net income loss of $7.7 million in contrast to a profit of $27.1 million in Q4 2023. The adjusted earnings per share (EPS) for Q4 was $0.46, a significant drop from last year’s $0.68, and 42% below expectations of $0.79.

Zacks Investment Research
Image Source: Zacks Investment Research

Declining EPS Estimates and Elevated P/E Ratios

In the past 30 days, EPS estimates for fiscal 2025 have been reduced by 13%, dropping from $4.81 to $4.56. This negative revision trend may persist following the company’s recent earnings miss, further impacting investor sentiment.

Zacks Investment Research
Image Source: Zacks Investment Research

Arcosa’s stock trades at a forward earnings multiple of 20.1X, which is above the industry average of 16.8X. Competitors such as CRH plc CRH and TopBuild BLD also feature in the sector, indicating there may be more competitive pricing pressures ahead.

Zacks Investment Research
Image Source: Zacks Investment Research

Conclusion

Arcosa’s ability to meet ambitious earnings growth expectations for FY25 remains uncertain. Continuous declines in earnings estimates may indicate further downside risks for ACA shares.

Just Released: Zacks Top 10 Stocks for 2025

Don’t miss your chance to explore our top 10 selected stocks for 2025. Curated by Zacks Director of Research Sheraz Mian, this portfolio has delivered remarkable success. From its inception in 2012 until November 2024, the Zacks Top 10 Stocks gained +2,112.6%, significantly outperforming the S&P 500’s +475.6%. Sheraz has evaluated 4,400 companies covered by the Zacks Rank to identify the top 10 opportunities for 2025. Be among the first to see this newly released list of promising stocks.

Want the latest recommendations from Zacks Investment Research? Download our report on the 7 Best Stocks for the Next 30 Days. Click to access your free report.

Arcosa, Inc. (ACA) : Free Stock Analysis report

TopBuild Corp. (BLD) : Free Stock Analysis report

CRH PLC (CRH) : Free Stock Analysis report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Subscribe to Pivot and Flow Daily